IFN-β improves BCG immunogenicity by acting on DC maturation

Journal of Leukocyte Biology

Volumn 85, Issue 3, 2009, Pages 462-468

  Giacomini, Elena ^a   Remoli, Maria Elena ^a   Gafa, Valérie ^a   Pardini, Manuela ^a   Fattorini, Lanfranco ^a   Coccia, Eliana M ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cytokines; IRF; Mycobacterium tuberculosis

Indexed keywords

BCG VACCINE; BETA1A INTERFERON; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ARTICLE; CELL MATURATION; CELL POLARITY; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOPHENOTYPING; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TUBERCULOSIS;

BCG VACCINE; DENDRITIC CELLS; HUMANS; INTERFERON-BETA; INTERLEUKIN-12; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TUBERCULOSIS VACCINES;

MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 61449109077     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0908583     Document Type: Article

References (40)

1. North, R. J., Jung, Y. J. (2004) Immunity to tuberculosis. Annu. Rev. Immunol. 22, 599-623.
2. Maartens, G., Wilkinson, R. J. (2007) Tuberculosis. Lancet 370, 2030-2043.
3. Young, D., Dye, C. (2006) The development and impact of tuberculosis vaccines. Cell 124, 683-687.
4. Flynn, J. L., Chan, J. (2001) Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129.
5. Holt, P. G., Schon-Hegrad, M. A. (1987) Localization of T cells, macro-phages and dendritic cells in rat respiratory tract tissue: implications for immune function studies. Immunology 62, 349-356.
6. Sertl, K., Takemura, T., Tschachler, E., Ferrans, V. J., Kaliner, M. A., Shevach, E. M. (1986) Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J. Exp. Med. 163, 436-451.
7. Van Haarst, J. M., Hoogsteden, H. C., de Wit, H. J., Verhoeven, G. T., Havenith, C. E., Drexhage, H. A. (1994) Dendritic cells and their precursors isolated from human bronchoalveolar lavage: immunocytologic and functional properties. Am. J. Respir. Cell Mol. Biol. 11, 344-350.
8. Steinman, R. M. (2006) Linking innate to adaptive immunity through dendritic cells. Novartis Found. Symp. 279, 101-109.
9. Trinchieri, G., Sher, A. (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7, 179-190.
10. Giacomini, E., Iona, E., Ferroni, L., Miettinen, M., Fattorini, L., Orefici, G., Julkunen, I., Coccia, E. M. (2001) Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166, 7033-7041.
11. Remoli, M. E., Giacomini, E., Lutfalla, G., Dondi, E., Orefici, G., Battis-tini, A., Uze, G., Pellegrini, S., Coccia, E. M. (2002) Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J. Immunol. 169, 366-374.
12. Lande, R., Giacomini, E., Grassi, T., Remoli, M. E., Iona, E., Miettinen, M., Julkunen, I., Coccia, E. M. (2003) IFN-αβ released by Mycobacterium
13. tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J. Immunol. 170, 1174-1182.
14. Giacomini, E., Sotolongo, A., Iona, E., Severa, M., Remoli, M. E., Gafa, V., Lande, R., Fattorini, L., Smith, I., Manganelli, R., Coccia, E. M. (2006) Infection of human dendritic cells with a Mycobacterium tuberculosis sigE mutant stimulates production of high levels of interleukin-10 but low levels of CXCL10: impact on the T-cell response. Infect. Immun. 74, 3296-3304.
15. Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., Uze, G. (2004) Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34, 796-805.
16. Gafa, V., Lande, R., Gagliardi, M. C., Severa, M., Giacomini, E., Remoli, M. E., Nisini, R., Ramoni, C., Di Francesco, P., Aldebert, D., Grillot, R., Coccia, E. M. (2006) Human dendritic cells following Aspergillus fumiga-tus infection express the CCR7 receptor and a differential pattern of interleukin-12 (IL-12), IL-23, and IL-27 cytokines, which lead to a Th1 response. Infect. Immun. 74, 1480-1489.
17. Hiscott, J. (2007) Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18, 483-490.
18. Goriely, S., Molle, C., Nguyen, M., Albarani, V., Haddou, N. O., Lin, R., De Wit, D., Flamand, V., Willems, F., Goldman, M. (2006) Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)-and TLR3-induced IL-12p35 gene activation. Blood 107, 1078-1084.
19. Remoli, M. E., Gafa, V., Giacomini, E., Severa, M., Lande, R., Coccia, E. M. (2007) IFN-β modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression. Eur. J. Immunol. 37, 3499-3508.
20. Yoshikai, Y. (2006) Immunological protection against Mycobacterium tuberculosis infection. Crit. Rev. Immunol. 26, 515-526.
21. Baumann, S., Nasser Eddine, A., Kaufmann, S. H. (2006) Progress in tuberculosis vaccine development. Curr. Opin. Immunol. 18, 438-448.
22. Seder, R. A., Darrah, P., Roederer, M. (2008) T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8, 247-258.
23. Pieters, J. (2008) Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 3, 399-407.
24. Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S., Orme, I. M. (2000) Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68, 6879-6882.
25. Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry III, C. E., Freedman, V. H., Kaplan, G. (2001) Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β. Proc. Natl. Acad. Sci. USA 98, 5752-5757.
26. Stanley, S. A., Johndrow, J. E., Manzanillo, P., Cox, J. S. (2007) The type I IFN response to infection with Mycobacterium tuberculosis requires
27. ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 178, 3143-3152.
28. Bouchonnet, F., Boechat, N., Bonay, M., Hance, A. J. (2002) α/β Inter-feron impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infect. Immun. 70, 3020-3025.
29. Giosue, S., Casarini, M., Alemanno, L., Galluccio, G., Mattia, P., Pedi-celli, G., Rebek, L., Bisetti, A., Ameglio, F. (1998) Effects of aerosolized interferon-a in patients with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 158, 1156-1162.
30. Giosue, S., Casarini, M., Ameglio, F., Zangrilli, P., Palla, M., Altieri, A. M., Bisetti, A. (2000) Aerosolized interferon-α treatment in patients with multi-drug-resistant pulmonary tuberculosis. Eur. Cytokine Netw. 11, 99-104.
31. Proietti, E., Bracci, L., Puzelli, S., Di Pucchio, T., Sestili, P., De Vincenzi, E., Venditti, M., Capone, I., Seif, I., De Maeyer, E., Tough, D., Donatelli, I., Belardelli, F. (2002) Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J. Immunol. 169, 375-383.
32. Bracci, L., La Sorsa, V., Belardelli, F., Proietti, E. (2008) Type I inter-ferons as vaccine adjuvants against infectious diseases and cancer. Expert Rev. Vaccines 7, 373-381.
33. Hiscott, J. (2007) Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282, 15325-15329.
34. Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G. P., Lin, R., Hiscott, J. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151.
35. Liu, J., Cao, S., Herman, L. M., Ma, X. (2003) Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-γ-primed IL-12 production by IFN regulatory factor 1. J. Exp. Med. 198, 1265-1276.
36. Gerosa, F., Baldani-Guerra, B., Lyakh, L., Batoni, G., Esin, S., Winkler-Pickett, R., Consolaro, M., De Marchi, M., Giachino, D., Robbiano, A., Astegiano, M., Sambataro, A., Kastelein, R., Carra, G., Trinchieri, G. (2008) Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205, 1447-1461.
37. Guinn, K. M., Hickey, M. J., Mathur, S. K., Zakel, K. L., Grotzke, J. E., Lewinsohn, D. M., Smith, S., Sherman, D. R. (2004) Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 51, 359-370.
38. Brodin, P., Rosenkrands, I., Andersen, P., Cole, S. T., Brosch, R. (2004) ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol. 12, 500-508.
39. Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., Stover, C. K. (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178, 1274-1282.
40. Van der Wel, N., Hava, D., Houben, D., Fluitsma, D., van Zon, M., Pierson, J., Brenner, M., Peters, P. (2007) M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129, 1287-1298.